Trials / Unknown
UnknownNCT04195269
Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet
Osteoarthritis of the Knee Pain Study Using CBD and THC in Rapidly Dissolvable Sublingual Tablet
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Pure Green · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective Phase 2, drug controlled, open-label study to evaluate the safety and efficacy of Pure Green sublingual tablets for the treatment of pain associated with osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test Article | 10 mg CBD, 10 mg of THC, and a proprietary blend of terpenes. |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2020-06-30
- Completion
- 2020-07-15
- First posted
- 2019-12-11
- Last updated
- 2020-04-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04195269. Inclusion in this directory is not an endorsement.